Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S -nitrosoglutathione

British Journal of Pharmacology

Volumn 124, Issue 1, 1998, Pages 141-148

  Gordge, M P ^a,b   Hothersall, J S ^a   Noronha Dutra, A A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Copper; Cyclic GMP; Cyclic GMP independent; Guanylate cyclase; Nitric oxide; Platelet aggregation; S nitrosoglutathione; Thiols

Indexed keywords

8 BROMO CYCLIC GMP; ANTITHROMBOCYTIC AGENT; CHELATING AGENT; CHLOROMERCURIBENZENESULFONIC ACID; COLLAGEN; CYCLIC AMP; CYCLIC GMP; DIETHYLAMINE; GUANYLATE CYCLASE; METHEMOGLOBIN; N ACETYL S NITROSOCYSTEINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; OXYHEMOGLOBIN; S NITROSOCYSTEINE; S NITROSOGLUTATHIONE; S NITROSOHOMOCYSTEINE; THIOL GROUP; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; SPECTROPHOTOMETRY; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE;

CELL MEMBRANE; CYCLIC AMP; CYCLIC GMP; GLUTATHIONE; HUMANS; HYDRAZINES; NITRIC OXIDE; NITROGEN OXIDES; NITROSO COMPOUNDS; OXADIAZOLES; PHENANTHROLINES; PLATELET AGGREGATION INHIBITORS; QUINOXALINES; S-NITROSOGLUTATHIONE; SULFHYDRYL COMPOUNDS;

EID: 0031920694     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701821     Document Type: Article

References (49)

1. + and NO donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch. Biochem. Biophys., 318, 279 - 285.
2. BARSONY, J. & MARX, S.J. (1990). Immunocytology on microwave-fixed cells reveals rapid and agonist-specific changes in subcellular accumulation patterns for cAMP or cGMP. Proc. Natl. Acad. Sci. U.S.A., 87, 1188 - 1192.
3. BAYER, E.A., ZALIS, M.G. & WICHEK, M. (1985). 3-(N-maleimidoproprionyl) biocytin: a versatile thiol-specific biotinylating reagent. Anal. Biochem., 149, 529 - 536.
4. BLAIR, D & DIEHL, H. (1961). Bathophenanthrolinedisulphonic acid and bathocuproinedisulphonic acid, water soluble reagents for iron and copper. Talanta, 7, 163 - 174.
5. BOLOTINA, V.M., NAJIBI, S., PALACINO, J.J., PAGANO, P.J. & COHEN, R.A. (1994). Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature, 368, 850 - 853.
6. BRUNNER, F., SCHMIDT, K., NIELSEN, E.B. & MAYER, B. (1996). Novel guanylylcyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J. Pharmacol. Exp. Ther., 277, 48 53.
7. CLANCY, R.M., LESZCZYNSKA-PIZIACK, J. & ABRAMSON, S.B. (1992). Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest., 90, 1116 1121.
8. CLANCY, R.M. LEVARTOVSKY, D., LESZCZYNSKA-PIZIAK, J., YEGUDIN, J. & ABRAMSON, S.B. (1994). Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary. Proc. Natl. Acad. Sci. U.S.A., 91, 3680 - 3684.
9. DAVISSON, R.L., TRAVIS, M.D., BATES, J.N. & LEWIS, S.J. (1996). Hemodynamic effects of L- and D-S-nitrosocysteine in the rat. Stereoselective S-nitrosothiol recognition sites. Circ. Res., 79, 256 - 262.
10. DE BELDER, A.J., MACALLISTER, R., RADOMSKI, M., MONCADA, S. & VALLANCE, P.J.T. (1994). Effects of S-nitrosoglutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc. Res., 28, 691 - 694.
11. DICKINSON, N.T., JANG, E.K. & HASLAM, R.J. (1997). Activation of cGMP-stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets: effects on platelet aggregation. Biochem. J., 323, 271 377.
12. 2+ as the effective reagent in nitric oxide formation from S-nitrosothiols (RSNO). J. Chem. Soc. Perkin Trans., 2, 481 487.
13. DO, K.Q., BENZ, B., GRIMA, G., GUTTECK-AMSLER, U., KLUGE, I & SALT, T.E. (1996). Nitric oxide precursor arginine and s-nitrosoglutathione in synaptic and glial function. Neurochem. Int., 29, 213 224.
14. DORN, G.W. (1990). Cyclic oxidation-reduction reactions regulate thromboxane A2/prostaglandin H2 receptor number and affinity in human platelet membranes. J. Biol. Chem., 265, 4240 4246.
15. EDWARDS, B.S., CURRY, M.S., SOUTHON, E.A., CHONG, A.S.K. & GRAK Jr, L.H. (1995). Evidence for a dithiol-activated signaling pathway in natural killer cell avidity regulation of leukocyte function antigen-1: structural requirements and relationship to phorbol ester- and CD 16-triggered pathways. Blood, 86, 2288 2301.
16. GARG, U.C. & HASSID, A. (1991). Nitric oxide decreases cytosolic free calcium in Balb/c 3T3 fibroblasts by a cyclic GMP-independent mechanism. J. Biol. Chem., 266, 9 12.
17. GARTHWAITE, J., SOUTHAM, E., BOULTON, C.L., NIELSEN, E.B., SCHMIDT, K. & MAYER, B. (1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one. Mol. Pharmacol., 48, 184 188.
18. GASTON, B., DRAZEN, J.M., JANSEN, A., SUGARBAKER, D.A., LOSCALZO, J., RICHARDS, W. & STAMLER, J.S. (1994). Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. J. Pharmacol. Exp. Ther., 268, 978 984.
19. GASTON, B., REILLY, J., DRAZEN, J.M., FACKLER, J., RAMDEV, P., ARNELLE, D., MULLINS, M.E., SUGARBAKER, D.J., CHEE, C., SINGEL, D.J., LOSCALZO, J. & STAMLER, J.S. (1993). Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc. Natl. Acad. Sci. U.S.A. 90, 10957 - 10961.
20. GIBSON, A., BABBEDGE, R., BRAVE, S.R., HART, S.L., HOBBS, A.J., TUCKER, J.F., WALLACE, P. & MOORE, P.K. (1992). An investigation of some S-nitrosothiols, and of hydroxy-arginine, on the mouse anococcygeus. Br. J. Pharmacol., 107, 715 721.
21. GORDGE, M.P., HOTHERSALL, J.S., NEILD, G.H. & NORONHADUTRA, A.A. (1996). Role of a copper (I)-dependent enzyme in the anti-platelet action of S-nitroglutathione. Br. J. Pharmacol., 119, 533 538.
22. GORDGE, M.P., MEYER, D., HOTHERSALL, J.S., NEILD, G.H., PAYNE, N.N. & NORONHA-DUTRA, A.A. (1995). Copper chelation - induced reduction of the biological activity of S-nitrosothiol. Br. J. Pharmacol., 114, 1083 1089.
23. HOGG, N., SINGH, J., KONOREV, E., JOSEPH, J. & KALYANARAMAN, B. (1997). S-nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase. Biochem. J., 323, 477 481.
24. IGNARRO, L.J. (1992). Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanism. Biochem. Soc. Trans., 20, 465 469.
25. IGNARRO, L.J. LIPTON, H., EDWARDS, J.C., BARICOS, W.H., HYMAN, A.L., KADOWITZ, P.J. & GRUETTER, C.A. (1981). Mechanism of vascular smooth muscle relaxation by organic nitrates, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther., 218, 739 749.
26. JIA, L., BONAVENTURA, C., BONAVENTURA, J. & STAMLER, J.S. (1996). S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature, 380, 221 226.
27. KELM, M., FEELISCH, M., SPAHR, R., PIPER, H., NOACK, E. & SCHRADER, J. (1988). Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells. Biochem. Biophys. Res. Commun., 154, 236 244.
28. KOWALUK, E.A. & FUNG, H. (1990). Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J. Pharmacol. Exp. Ther., 256, 1256 1264.
29. LANDER, H.M., HAJJAR, D.P., HEMPSTEAD, B.L., MIRZA, U.A., CHAIT, B.T., CAMPBELL, S. & QUILLIAM, L.A. (1997). A molecular redox switch on p21ras. Structural basis for the nitric oxide-p21 ras interaction. J. Biol. Chem., 272, 4323 4326.
30. LANGFORD, E.J., BROWN, A.S., WAINWRIGHT, R.J., DE BELDER, A.J., THOMAS, M.R., SMITH, R.E.A., RADOMSKI, M.W., MARTIN, J.E. & MONCADA, S. (1994). Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet, 344, 1458 - 1460.
31. LAW, D.A., NANNIZZI-ALAIMO, L. & PHILLIPS, D.R. (1996). Outside-in integrin signal transduction. alphallbbeta3 (GPIIb-IIIa) tyrosine phosphorylation induced by platelet aggregation. J Biol. Chem., 271, 10811 10815.
32. LIEBERMAN, E.H., O'NEILL, S. & MENDELSOHN, M.E. (1991). S-nitrosocysteine inhibition of human platelet secretion is correlated with increases in platelet cGMP levels. Circ. Res., 68, 1722 1728.
33. MACALLISTER, R.J., CALVER, A.L., RIEZEBOS, J., COLLIER, J. & VALLANCE, P. (1995). Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery. J. Pharmacol. Exp. Ther., 273, 154 160.
34. MATHEWS, W.R. & KERR, S.W. (1993). Biological activity of S-nitrosothiols: the role of nitric oxide. J. Pharmacol. Exp. Ther., 267, 1529 1537.
35. MELLION, B.T., IGNARRO, L.J., MYERS, C.B., OHLSTEIN, E.H., BALLOT, B.A., HYMAN, A.L. & KADOWITZ, P.J. (1983). Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mol. Pharmacol., 23, 653 - 664.
36. MOHR, S., STAMLER, J.S. & BRUNE, B. (1994). Mechanism of covalent modification of glyceraldehyde-3-phosphate dehydro-genase at its active site by nitric oxide, peroxynitrite and related nitrosating agents. FEBS Lett., 348, 223 227.
37. MORLEY, M. & KEEFER, L.K. (1993). Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J. Cardiovasc. Pharmacol., 22 (Suppl 7), S3 S9.
38. MORO, M.A., RUSSELL, R.J., CELLEK, S., LIZASOAIN, I., SU, Y., DARLEY-USMAR, V., RADOMSKI, M.W. & MONCADA, S. (1996), cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanyl cyclase. Proc. Natl. Acad. Sci. U.S.A., 93, 1480 - 1485.
39. NAKATSU, K. DIAMOND, J. (1989). Role of cGMP in relaxation of vascular and other smooth muscle. Can. J. Physiol. Pharmacol., 67, 251 262.
40. NASEEM, K.M., CHIRICO, S., MOHAMMADI, B & BRUCKDORFER, K.R. (1996). The synergism of hydrogen peroxide with plasma S-nitrosothiols in the inhibition of platelet activation. Biochem. J., 318, 759 766.
41. PURI, R.N., MATSUEDA, R., UMEYAMA, H., BRADFORD, H.N. & COLMAN, R.W. (1993). Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine. Eur. J. Biochem., 214, 233 241.
42. RADOMSKI, M.W., REES, D.D., NORONHA-DUTRA, A. & MONCADA, S. (1992). S-nitroso-glulathione inhibits platelet activation in vitro and in vivo. Br. J. Pharmacol., 107, 745 749.
43. SCHRAMMEL, A., BEHRENDS, S., SCHMIDT, K., KOESLING, D. & MAYER, B. (1996). Characterisation of 1H-[1,2,4]oxoadiazolo[4,3-a]quinoxalin-1-one as a heme site inhibitor of nitric oxide-sensitive guanyly cyclase. Mol. Pharmacol., 50, 1 5.
44. SEXTON, D.J. & MUTUS, B. (1995). Platelet glutathione transport: characteristics and evidence for regulation by intraplatelet thiol status. Biochem. Cell Biol., 73, 155 162.
45. SINGH, R.J., HOGG, N., JOSEPH, J. & KALYANARAMAN, B. (1996). Mechanism of nitric oxide release from S-nitrosothiols. J. Biol. Chem., 271, 18596 18603.
46. STAMLER, J.S. (1994). Redox signalling: nitrosylation and related target interactions of nitric oxide. Cell, 78, 931 936.
47. STAMLER, J.S. (1996). A radical vascular connection. Nature, 380, 108 111.
48. STAMLER, J.S., JARAKI, O., OSBORNE, J., SIMON, D.I., KEANEY, J., VITA, J., SINGEL, D., VALERI, C.R. & LOSCALZO, J. (1992). Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. U.S.A. 89, 7674 7677.
49. ZUCKER, M.B. & MAUSS, E.A. (1986). Modification of platelet functions by monobromobimane, a fluorescent thiol group label. Thromb. Haemostas., 55, 228 234.